Search results
Nov 16, 2021 · November 16, 2021. Colby remembers the life and scholarship of Clifford E. Reid, the Charles A. Dana Professor of Economics, Emeritus, who died Nov. 6, 2021, in Waterville, Maine, at 76. Reid was a distinguished scholar on discrimination in American life who taught at the College from 1987 to 2009. Reid had a profound impact on his colleagues ...
Clifford James Reed. See Photos. View the profiles of people named Clifford Reid. Join Facebook to connect with Clifford Reid and others you may know. Facebook gives people the power to...
Nov 20, 2021 · Passed away in Waterville, Maine, on November 6, 2021. Cliff grew up in Washington, DC, and graduated from Calvin Coolidge High School. He received a bachelor's degree in economics from George...
- November 6, 2021
Nov 26, 2021 · November 26, 2021. Clifford E. Reid, the Charles A. Dana Professor of Economics, Emeritus at Colby College, died on November 6, in Waterville, Maine. He was 76 years old. Reid was a distinguished scholar on discrimination in American life who taught at Colby College for 22 years.
- Broker Clifford Reid Allegedly Misrepresented Investments
- Reid Rudiger Investor Suggests That Clifford Reid Misrepresented Investments
- Reid Allegedly Made Unsuitable Trades in Reid Rudiger Client’S Account
- Reid Rudiger Investor Indicates That Clifford Reid breached A Fiduciary Duty
- Reid Allegedly Fails to Place Stop Loss in Reid Rudiger Client’S Account
- Did Reid Rudiger Securities Broker Clifford Reid Sell You Bad Investments?
Soreide Law Group is looking into potential investor disputes against securities broker Clifford Reid [CRD#: 1905920, New York, New York]. Evidently, Financial Industry Regulatory Authority (“FINRA”) BrokerCheck shows that at least 7 clients took issue with the securities broker, who started with Reid Rudiger in 1999. Notably, clients of Reid Rudig...
Apparently, on November 8, 2019, a Reid Rudiger client filed FINRA Arbitration #: 19-02993 concerning Clifford Reid. Notably, the client contended that Reid falsified important information about the client’s stock holdings. Supposedly, he failed to comply with his fiduciary responsibility and engaged in unsupervised transactions. Therefore, the cli...
Evidently, on October 25, 2019, a Reid Rudiger client filed FINRA Arbitration #: 19-02808 about Clifford Reid. Allegedly, Reid effected unsuitable trades in the client’s account; transactions which were not in line with the client's investment profile. Not only that, but it appears that the securities broker possibly made excessive and negligent tr...
It appears that a client of Reid Rudiger contested Clifford Reid’s actions by bringing FINRA Arbitration #: 19-02676 on October 25, 2019. Notably, Reid allegedly breached his fiduciary responsibility. Allegedly, he failed to place the client’s interest first. The client suggested that the securities broker made inappropriate trades in the client’s ...
Apparently, on January 19, 2019, a Reid Rudiger client filed FINRA Arbitration #: 15-04303 concerning Clifford Reid. Mainly, the client contended that Reid failed to place a stop loss order according to the client’s instructions. As a result, the client experienced losses on over the counter equities. Therefore, on August 14, 2019, Reid Rudiger set...
Have you experienced losses by investing with Clifford Reid? If so, reach out to Soreide Law Group at (888) 760-6552 and speak with experienced counsel in regard to possibly recovering your investment losses. Soreide Law Group represents clients on a contingency fee basis and will advance all costs. The law firm has recovered millions of dollars fo...
Clifford R. Reid is a founding partner of Reid & Rudiger LLC, a research-generated boutique broker dealer in New York City. Mr. Reid has over 29 years of experience in the equity market and works closely with the firm’s clients in selecting investments that meet their objectives.
CEO at Travera. Show contact. Clifford Reid is the founding CEO of Travera. Previously, Dr. Reid was the founding Chairman, President and Chief Executive Officer of Complete Genomics (NASDAQ:GNOM), a leading developer of whole human genome DNA sequencing technologies and services.
